{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:15:39Z","timestamp":1780431339786,"version":"3.54.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disorder. The most devastating variant is bulbar-onset ALS, which portends a median survival of 24 months from the onset of symptoms. Abundant evidence indicates that neuron metabolism and mitochondrial function are impaired in ALS. Metabolic strategies, particularly fasting and ketogenic diet protocols, alter neuron metabolism and mitochondria function in a manner that may mitigate the symptoms of this disorder. We report the case of a 64-year-old man with a 21-month history of progressive, deteriorating bulbar-onset ALS, with an associated pseudobulbar affect, who implemented a time-restricted ketogenic diet (TRKD) for 18 months. During this time, he improved in ALS-related function (7% improvement from baseline), forced expiratory volume (17% improvement), forced vital capacity (13% improvement), depression (normalized), stress levels (normalized), and quality of life (19% improvement), particularly fatigue (23% improvement). His swallowing impairment and neurocognitive status remained stable. Declines were measured in physical function, maximal inspiratory pressure, and maximal expiratory pressure. Weight loss was attenuated and no significant adverse effects occurred. This case study represents the first documented occurrence of a patient with ALS managed with either a fasting or ketogenic diet protocol, co-administered as a TRKD. We measured improved or stabilized ALS-related function, forced expiratory volume, forced vital capacity, swallowing, neurocognitive status, mood, and quality of life. Measurable declines were restricted to physical function, maximal inspiratory pressure, and maximal expiratory pressure. Now over 45 months since symptom onset, our patient remains functionally independent and dedicated to his TRKD.<\/jats:p>","DOI":"10.3389\/fneur.2023.1329541","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T04:35:22Z","timestamp":1705552522000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Time-restricted ketogenic diet in amyotrophic lateral sclerosis: a case study"],"prefix":"10.3389","volume":"14","author":[{"given":"Matthew C. L.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel E.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rognvald J.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: an update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr Opin Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"12408","DOI":"10.1038\/ncomms12408","article-title":"Projected increase in amyotrophic lateral sclerosis from 2015 to 2040","volume":"7","author":"Arthur","year":"2016","journal-title":"Nat Commun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur J Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/14737175.2020.1788389","article-title":"Understanding and managing metabolic dysfunction in amyotrophic lateral sclerosis","volume":"20","author":"Blasco","year":"2020","journal-title":"Expert Rev Neurother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","article-title":"Mitochondrial dysfunction in ALS","volume":"97","author":"Cozzolino","year":"2012","journal-title":"Prog Neurobiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","article-title":"Energy metabolism in amyotrophic lateral sclerosis","volume":"10","author":"Dupuis","year":"2011","journal-title":"Lancet Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/WCO.0000000000000982","article-title":"Dysregulation of energy homeostasis in amyotrophic lateral sclerosis","volume":"34","author":"Guillot","year":"2021","journal-title":"Curr Opin Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"132933","DOI":"10.1016\/j.neulet.2017.06.052","article-title":"The role of mitochondria in amyotrophic lateral sclerosis","volume":"710","author":"Smith","year":"2019","journal-title":"Neurosci Lett."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3390\/cells11132049","article-title":"The impact of mitochondrial dysfunction in amyotrophic lateral sclerosis","volume":"11","author":"Zhao","year":"2022","journal-title":"Cells."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1523\/JNEUROSCI.18-09-03241.1998","article-title":"Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1","volume":"18","author":"Kong","year":"1998","journal-title":"J Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"18916","DOI":"10.1038\/s41598-021-97928-7","article-title":"Neuronal mitochondrial dysfunction in sporadic amyotrophic lateral sclerosis is developmentally regulated","volume":"11","author":"Singh","year":"2021","journal-title":"Sci Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.14336\/AD.2021.1018","article-title":"Metabolic strategies in healthcare: a new era","volume":"13","author":"Phillips","year":"2022","journal-title":"Aging Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1301\/nr.2003.oct.327-341","article-title":"Ketones: metabolism's ugly duckling","volume":"61","author":"VanItallie","year":"2003","journal-title":"Nutr Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/152165401753311780","article-title":"Ketone bodies, potential therapeutic uses","volume":"51","author":"Veech","year":"2001","journal-title":"IUBMB Life."},{"key":"B16","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1177\/0883073813487595","article-title":"Ketogenic diets and pain","volume":"28","author":"Masino","year":"2013","journal-title":"J Child Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of intermittent fasting on health, aging, and disease","volume":"381","author":"de Cabo","year":"2019","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2202-7-29","article-title":"A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis","volume":"7","author":"Zhao","year":"2006","journal-title":"BMC Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e49191","DOI":"10.1371\/journal.pone.0049191","article-title":"Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS ONE."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","article-title":"A proposal for new diagnostic criteria for ALS","volume":"131","author":"Shefner","year":"2020","journal-title":"Clin Neurophysiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurol Sci."},{"key":"B23","first-page":"387","article-title":"Balance in elderly patients: the \u2018get-up and go' test","volume":"67","author":"Mathias","year":"1986","journal-title":"Arch Phys Med Rehabil."},{"key":"B24","article-title":"The six-minute walk test","author":"Enright","year":"2003","journal-title":"Respir Care."},{"key":"B25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.apmr.2007.02.004","article-title":"Is stair climb power a clinically relevant measure of leg power impairments in at-risk older adults?","volume":"88","author":"Bean","year":"2007","journal-title":"Arch Phys Med Rehabil."},{"key":"B26","volume-title":"Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).","author":"Randolph","year":"1998"},{"key":"B27","volume-title":"Wechsler Adult Intelligence Scale\u2013Fourth Edition (WAIS\u2013IV).","author":"Wechsler","year":"2008"},{"key":"B28","volume-title":"Delis-Kaplan Executive Function System","author":"Delis","year":"2001"},{"key":"B29","volume-title":"Multilingual Aphasia Examination (3rd ed).","author":"Benton","year":"1994"},{"key":"B30","volume-title":"Manual for the Depression Anxiety Stress Scales (2nd ed.).","author":"Lovibond","year":"1995"},{"key":"B31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0885-3924(96)00274-6","article-title":"Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system","volume":"13","author":"Yellen","year":"1997","journal-title":"J Pain Symptom Manage."},{"key":"B32","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1126\/science.aau2096","article-title":"Dietary fat: from foe to friend?","volume":"362","author":"Ludwig","year":"2018","journal-title":"Science."},{"key":"B33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.yebeh.2016.02.038","article-title":"Establishing an adult epilepsy diet center: experience, efficacy and challenges","volume":"58","author":"Cervenka","year":"2016","journal-title":"Epilepsy Behav."},{"key":"B34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13024-017-0217-5","article-title":"Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients","volume":"12","author":"Konrad","year":"2017","journal-title":"Mol Neurodegener."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1212\/WNL.0000000000000951","article-title":"The PRO-ACT database: design, initial analyses, and predictive features","volume":"83","author":"Atassi","year":"2014","journal-title":"Neurology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"105456","DOI":"10.1016\/j.clineuro.2019.105456","article-title":"The prognostic value of spirometric tests in amyotrophic lateral sclerosis patients","volume":"184","author":"Pirola","year":"2019","journal-title":"Clin Neurol Neurosurg."},{"key":"B37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1590\/S1806-37132015000004474","article-title":"Diagnostic methods to assess inspiratory and expiratory muscle strength","volume":"41","author":"Caruso","year":"2015","journal-title":"J Bras Pneumol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/mus.27244","article-title":"The cumulative incidence of dysphagia and dysphagia-free survival in persons diagnosed with amyotrophic lateral sclerosis","volume":"64","author":"Perry","year":"2021","journal-title":"Muscle Nerve."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/01.wnl.0000055861.95202.8d","article-title":"Are amyotrophic lateral sclerosis patients cognitively normal?","volume":"60","author":"Lomen-Hoerth","year":"2003","journal-title":"Neurology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","article-title":"Prevalence and patterns of cognitive impairment in sporadic ALS","volume":"65","author":"Ringholz","year":"2005","journal-title":"Neurology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1096\/fj.02-1182fje","article-title":"Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis","volume":"17","author":"Dupuis","year":"2003","journal-title":"FASEB J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"20240","DOI":"10.1074\/jbc.M102540200","article-title":"In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism","volume":"276","author":"Cline","year":"2001","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.25661","article-title":"Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis","volume":"87","author":"Ludolph","year":"2020","journal-title":"Ann Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/S0140-6736(14)60222-1","article-title":"Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"383","author":"Wills","year":"2014","journal-title":"Lancet."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1329541\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T04:35:29Z","timestamp":1705552529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1329541\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":44,"alternative-id":["10.3389\/fneur.2023.1329541"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1329541","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"article-number":"1329541"}}